Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ MCG10 Antibody Blocking Peptide
SDP

Catalog No. NBP176729E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP176729E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP176729E Supplier Novus Biologicals™ Supplier No. NBP176729PEP
Add to Cart
Add to Cart

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 17 amino acids near the carboxy terminus of human MCG10C. Source: Synthetic (Accession #: EAW65166) The MCG10 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 57060
Species Human
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-76729. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias alpha-CP4, alphaCP-4 protein, CBP, LIP4, LYST-interacting protein, MCG10, poly(rC) binding protein 4, poly(rC)-binding protein 4, RNA binding protein MCG10
Gene Symbol PCBP4
Product Type MCG10
Quantity 0.05 mg
Regulatory Status RUO - research use only
Source Synthetic
Termination 17 amino acids near the carboxy terminus of human MCG10C
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.